LIU JEAN I 4

What Happened

• Jean I. Liu, a non-employee director of Connect Biopharma Holdings Ltd (CNTB), was granted 6,718 fully vested ordinary shares on June 30, 2026. The Form 4 reports the acquisition price as $0.00, reflecting a non-cash award issued in lieu of cash director fees.

Key Details

• Transaction date: 2026-06-30; reported on Form 4 filed 2026-07-01.
• Reported acquisition price: $0.00 (award/grant, transaction code A).
• Shares owned after the transaction: not specified in the filing.
• Footnote: The shares were issued under the company’s Non-Employee Director Compensation Program; Ms. Liu elected to receive shares instead of cash. The number of shares was calculated by dividing the equity value of her retainer by the 30-day average closing price through June 30, 2026 (rounded down).
• Filing timeliness: filed the next day — no late filing indicated.

Context

• This was a compensation award (shares in lieu of cash), not an open-market purchase or sale. Such grants are routine for non-employee directors and reflect how the company pays board retainers, not necessarily the director’s personal market sentiment. The shares were fully vested at grant.